全文获取类型
收费全文 | 23092篇 |
免费 | 1311篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 220篇 |
儿科学 | 625篇 |
妇产科学 | 922篇 |
基础医学 | 3223篇 |
口腔科学 | 560篇 |
临床医学 | 2078篇 |
内科学 | 4527篇 |
皮肤病学 | 566篇 |
神经病学 | 2530篇 |
特种医学 | 1089篇 |
外国民族医学 | 3篇 |
外科学 | 2991篇 |
综合类 | 175篇 |
一般理论 | 41篇 |
预防医学 | 1529篇 |
眼科学 | 294篇 |
药学 | 1589篇 |
中国医学 | 68篇 |
肿瘤学 | 1448篇 |
出版年
2022年 | 208篇 |
2021年 | 424篇 |
2020年 | 264篇 |
2019年 | 393篇 |
2018年 | 458篇 |
2017年 | 327篇 |
2016年 | 423篇 |
2015年 | 445篇 |
2014年 | 675篇 |
2013年 | 836篇 |
2012年 | 1336篇 |
2011年 | 1410篇 |
2010年 | 740篇 |
2009年 | 673篇 |
2008年 | 1060篇 |
2007年 | 1143篇 |
2006年 | 1193篇 |
2005年 | 1042篇 |
2004年 | 931篇 |
2003年 | 941篇 |
2002年 | 877篇 |
2001年 | 706篇 |
2000年 | 721篇 |
1999年 | 540篇 |
1998年 | 290篇 |
1997年 | 239篇 |
1996年 | 142篇 |
1995年 | 150篇 |
1994年 | 120篇 |
1993年 | 154篇 |
1992年 | 360篇 |
1991年 | 319篇 |
1990年 | 349篇 |
1989年 | 331篇 |
1988年 | 301篇 |
1987年 | 308篇 |
1986年 | 287篇 |
1985年 | 260篇 |
1984年 | 183篇 |
1983年 | 170篇 |
1979年 | 208篇 |
1978年 | 129篇 |
1977年 | 122篇 |
1976年 | 119篇 |
1975年 | 166篇 |
1974年 | 178篇 |
1973年 | 149篇 |
1972年 | 151篇 |
1971年 | 123篇 |
1970年 | 138篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
51.
Hermann J Girschick Etienne Mornet Meinrad Beer Monika Warmuth-Metz Peter Schneider 《BMC pediatrics》2007,7(1):3
Background
Hypophosphatasia (HP) is characterized by a genetic defect in the tissue-nonspecific alkaline phosphatase (TNSALP) gene and predominantly an autosomal recessive trait. HP patients suffer from reduced bone mineralization. Biochemically, elevated concentrations of substrates of TNSALP, including pyridoxal-5'-phosphate and inorganic pyrophosphate occur in serum, tissues and urine. The latter has been associated with chronic inflammation and hyperprostaglandinism. 相似文献52.
Claudia St?llberger Josef Finsterer Birke Schneider 《Journal of the American College of Cardiology》2006,47(7):1500; author reply 1500-1500; author reply 1501
53.
54.
Ira R Katz Marcia Rupnow Chris Kozma Lon Schneider 《The American journal of geriatric psychiatry》2004,12(5):499-508
OBJECTIVE: Authors evaluated the association between use/dosage of risperidone (RIS) and falls in a residential-care dementia population. METHODS: Authors performed secondary analysis of data from ambulatory patients in a randomized, double-blind, placebo-controlled, 12-week trial of three RIS dosages (0.5 mg/day, 1 mg/day, 2 mg/day). Outcomes included number of fallers, rate of falls, and time until the first fall after randomization. Additional analyses evaluated wandering as a potential moderating or mediating variable. RESULTS: The ambulatory sample included 537 subjects. Of those, 22.3% on placebo, 18.0% on RIS 0.5 mg/day, 12.7% on 1 mg/day, and 27.3% on 2 mg/day, respectively, fell during the trial. The difference between the RIS 1 mg/day group and placebo was significant, with a significantly lower hazard ratio in the RIS 1-mg/day group than placebo. Wandering was associated with an increased risk of falls. Among 205 patients with the highest levels of wandering at baseline, RIS 1 mg/day was associated with approximately a 70% reduction in risk for falls versus placebo condition. However, in those with the lowest levels of wandering at baseline, RIS 2 mg/day may have increased the risk of falls. CONCLUSIONS: Evaluating the benefits versus risks of risperidone in patients with dementia is complex and must consider multiple outcomes as a function of dose. At 1 mg/day, RIS was associated with decreased falls, especially in patients who exhibit wandering. However, at 2 mg/day, it may increase the risk of falls in ambulatory individuals with low levels of wandering. 相似文献
55.
Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes. 总被引:2,自引:0,他引:2
Christian Delles Markus P Schneider Sebastian Oehmer Ingrid Fleischmann Erwin F Fleischmann Roland E Schmieder 《Nephrology, dialysis, transplantation》2004,19(10):2513-2518
BACKGROUND: Reactive oxygen species play a major role in the development of endothelial dysfunction. It is as yet unspecified whether increased oxidative stress contributes to endothelial dysfunction of the renal vasculature in patients with type 2 diabetes. METHODS: Renal haemodynamics were studied in 20 patients with type 2 diabetes and arterial hypertension (age 62 +/- 5 years) and 20 non-diabetic hypertensive patients at baseline and following infusions of the nitric oxide synthase inhibitor, N(G)-monomethyl-L-arginine (L-NMMA; 4.25 mg/kg); the substrate of nitric oxide synthase, L-arginine (100 mg/kg); and the antioxidant, vitamin C (3 g, co-infused with L-arginine 100 mg/kg). RESULTS: The response of renal plasma flow (RPF) to L-NMMA (-54 +/- 62 and -45 +/- 42 ml/min/1.73 m(2); P = NS) and L-arginine (+46 +/- 36 and +49 +/- 25 ml/min/1.73 m(2); P = NS) was not different between diabetic and non-diabetic patients. In contrast, vitamin C induced a more pronounced increase in RPF in diabetic than in non-diabetic patients when co-infused with L-arginine (+71+/-47 and +43+/-33 ml/min/1.73 m(2); P<0.05). CONCLUSIONS: The difference in the response of renal perfusion to an antioxidant suggests increased formation of reactive oxygen species and thereby reduced nitric oxide bioavailability in the renal vasculature of patients with type 2 diabetes. 相似文献
56.
Dr. R. Schwab C. Schneider K. Junge M. Stumpf H. P. Becker V. Schumpelick 《Der Chirurg》2004,75(2):200-205
The solitary fibrous tumor (SFT) is a very rare and usually benign neoplasm. This tumor is mostly located in the thoracic cavity, but it has also been reported in numerous sites including liver, skin, and meninges. Due to its rarity diagnosis is often difficult. Accordingly, histopathological differentiation is of major importance. Solitary fibrous tumors consistently express CD 34 and react negatively to epithelial markers. This absence of expression of epithelial markers, especially cytokeratin, is also useful to distinguish these rare entities from sarcomatous mesotheliomas. The treatment of choice for solitary fibrous tumors is extensive surgical resection. Up to now there is no evidence that radiation and chemotherapy are effective. The local recurrence or onset of metastases depends on histologic parameters. In cases of benign classification (60-80%), the recurrence rate was only 2% after surgical excision. One-half of the patients with malignant tumors can be cured; the rest develop recurrences and metastases more often. Especially in those cases, emphasis should be placed on continual follow-up examination. We report two cases of a 65- and a 75-year-old male patient with huge intrathoracic solitary fibrous subpleural tumors, discovered incidentally on routine chest X-ray. 相似文献
57.
Samuel B Adams Paul R Herz Debra L Stamper Mark J Roberts Stephane Bourquin Nirlep A Patel Karl Schneider Scott D Martin Sonya Shortkroff James G Fujimoto Mark E Brezinski 《Journal of orthopaedic research》2006,24(4):708-715
The objective of this study was to develop and verify a new technique for monitoring the progression of osteoarthritis (OA) by combining a rat model with the imaging modality optical coherence tomography (OCT). Time-sequential, in vivo, OCT imaging was performed on the left femoral condyles of 12 Wistar rats following sodium-iodoacetic acid-induced OA progression. The right femoral condyles (untreated) were also imaged and served as controls. Imaging was performed on days 0, 10, 20, 30, and 60 with an OCT system capable of acquiring images at four frames per second and an axial resolution of 5 microm. Progressive changes were analyzed using an OA scoring system. OCT successfully identified progressive cartilage degeneration as well as alteration of the cartilage/bone interface. Significant changes to both of these structures were observed in the sodium-iodoacetic acid-injected condyles. Structural changes detected with OCT were confirmed histologically. OCT in combination with a well-known model used in arthritis research represents a powerful tool for following degenerative joint disease progression in a given animal by detecting changes to the cartilage/bone interface and articular cartilage. 相似文献
58.
Dr. Mark C. Granberry Pharm.D. Dr. Stephanie F. Gardner Pharm.D. Dr. Eric F. Schneider Pharm.D. Dr. Inge R. Carter M.D. 《Pharmacotherapy》1996,16(5):932-936
Study Objective . To determine if one commercial extended-release formulation of nifedipine (Adalat CC) is as effective as another (Procardia XL) in controlling blood pressure over 24 hours. Design . Open-label, randomized, crossover study. Setting . University-affiliated family medicine clinic. Patients . Fifteen patients with stage 1–4 primary hypertension. Interventions . Procardia XL or Adalat CC once/day was titrated to achieve blood pressure control. The effective dose was continued for 4 weeks, washed out for 1 week, and reinstituted with other study drug. Measurements and Main Results . Twenty-four-hour ambulatory blood pressure was recorded the conclusion of each treatment phase. Treatment phases were compared for mean 24-hour blood pressure, mean daytime (6:00 a.m.–10:00 p.m.) and mean nighttime blood pressure, and mean blood pressure load (percentage of blood pressure measurements < 140/90 mm Hg daytime and > 120/80 mm Hg nighttime). Thirteen patients completed the study. No statistically significant difference was seen in mean 24-hour blood pressure (138/86 mm Hg for Procardia XL vs 137/85 mm Hg for Adalat CC), daytime or nighttime blood pressure, or blood pressure load. Two patients experienced clinically significant adverse effects while taking Adalat CC. Conclusions . In these patients with primary hypertension, Adalat CC was as effective as Procardia XL at controlling blood pressure for 24 hours. Blood pressure, heart rate, and adverse effects should be monitored 2–4 weeks after any exchange of Adalat CC for Procardia XL. 相似文献
59.
Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. 总被引:2,自引:0,他引:2
J Mayer U Weichler B Herres-Mayer H Schneider U Marx J H Peter 《Journal of cardiovascular pharmacology》1990,16(6):952-961
Up to 50% of hypertensive men are subject to sleep apnea (SA). With a prevalence in men of up to 10%, SA is a common illness and hypertension (HT) one of its early symptoms. It is important to have available a drug treatment that will effectively control blood pressure (BP) without exacerbating symptoms of SA. Twelve patients with SA and HT were investigated in a double-blind, comparative trial. Patients were randomly allocated to either metoprolol (M) 100 mg daily or cilazapril (C) 2.5 mg daily. Polysomnographic measurements under standardized conditions including intraarterial BP monitoring were taken on two consecutive nights each before and after the 1-week treatment. Values in the M group were (mean +/- 95% CI) systolic BP 161 +/- 2.1 vs. 148 +/- 2.2 mm Hg (p less than 0.01); diastolic BP 98 +/- 1.8 vs. 93 +/- 1.8 mm Hg (p less than 0.01); and HR 73 +/- 1.2 vs 65 +/- 1.1 beats/min (p less than 0.01). Corresponding figures for the C group were systolic BP 140 +/- 2.1 vs. 127 +/- 2.1 mm Hg (p less than 0.01); diastolic BP 95 +/- 1.7 vs. 78 +/- 1.7 mm Hg (p less than 0.01); and HR 82 +/- 1.1 vs. 79 +/- 1.2 beats/min (p less than 0.01). Whereas C reduced both BP and HR in all sleep phases, M produced no changes during REM sleep. SA activity was 45 (range 15-91) vs. 34 (range 2-57) apneas per hour of sleep in the M group and 54 (range 21-84) vs. 40 (range 8-72) apneas per hour in the C group (p less than 0.01). There were no changes in total sleep time or in the proportions of non-REM to REM sleep. Both M and C reduce nocturnal BP in SA patients, but the effect of C is seen in all sleep phases. C has a more favorable effect on the disturbed nocturnal blood pressure of SA patients. 相似文献
60.
Copolymerization of propene with 1-octene (1 mol/1 mol) was performed in toluene at 40°C in the presence of homogeneous methylaluminoxane (MAO)-activated ansa-metallocenes in order to study the role of benzannelation and 2-methyl-substitution of the silylene-bridged bisindenyl ligand on comonomer incoporation, molecular mass, molecular mass distribution, and end groups. While 2-methyl-substitution promoted higher degree of polymerization without affecting copolymerization parameters, benzannelation improved markedly 1-octene incorporation. Only with MAO-activated rac-Me2Si(2-MeBenz[e]Ind)2ZrCl2 catalysts vinylidene end groups were formed exclusively. Molecular weight distribution remains narrow in all experiments. 相似文献